StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training

StARR 跨学科肿瘤学临床医生-科学家培训计划

基本信息

  • 批准号:
    10592756
  • 负责人:
  • 金额:
    $ 42.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT The over-arching goal of the Washington University (WU) StARR Program in Cross-Disciplinary Oncology Clinician Scientist Training is to IDENTIFY, RECRUIT, TRAIN, RETAIN, and ADVANCE outstanding physicians in oncology-focused graduate medical education (GME) training (i.e. “residency”) for careers as clinician- investigators. We have proposed training clinician resident-investigators from diverse, oncology-focused disciplines and residency training programs. Long-term objectives: The WU NCI R38 StARR program will successfully identify, recruit, and train oncology- focused clinicians with an interest in becoming clinician-scientists during their residency training. These trainees would then be eligible for subsequent career-development awards, including the companion K38 mechanism. Our program plan includes continued long-term follow-up and engagement of R38 trainees to retain and advance their careers as physician-scientists. Key Elements of Training: An emphasis of our proposal includes multiple levels of career development, including co-mentoring by at least two mentors in different departments to encourage cross-disciplinary training and collaboration. Each resident-investigator will also have a mentoring committee and report regularly to the PI and Advisory Committee. A structured curriculum with specific competencies and milestones will be established to best train individual resident-investigators in programs and research programs that are ideally matched with their skills, interests, and career development. We have received broad support from all levels of research and education at WU, including the Dean’s Office and the participating Departments and Programs. Research Projects: The WU NCI R38 StARR program will support up to four resident-investigators per year from the participating departments. Each resident-investigator will engage in 1-2 years of dedicated, protected research time, free from all clinical responsibilities. They will craft a research plan commensurate with their interests and prior experiences that may involve further training, coursework, workshops, and career development. Specific metrics and plans for follow-up, evaluation, and long-term mentoring and career development are included in our proposal. The WU StARR Program in Cross-Disciplinary Oncology Clinician Scientist Training will leverage the significant institutional, departmental, and programmatic resources at our University to meet the stated goal of the StARR program to recruit and retain outstanding health professionals to foster their careers as clinician-investigators.
项目摘要/摘要 华盛顿大学(WU)Starr计划的跨学科肿瘤学计划的整理目标 临床医生培训是识别,招募,培训,保留和进步的杰出医生 专注于肿瘤学的研究生医学教育(GME)培训(即“居住”)职业作为临床 - 调查人员。我们提出了培训来自潜水员的临床居民评估者,以肿瘤学为重点 学科和居住培训计划。 长期目标:Wu NCI R38 Starr计划将成功识别,招募和培训肿瘤学 - 专注的临床医生有兴趣在他们的居住培训中成为临床科学家。这些受训者 然后,将有资格获得随后的职业发展奖项,包括伴侣K38机制。 我们的计划计划包括持续的长期随访和R38学员的参与,以保留和进步 他们作为身体科学家的职业。 培训的关键要素:我们的建议的重点包括多个职业发展,包括 不同部门的至少两个导师会共同授权,以鼓励跨学科培训和 合作。每个居民评估者还将有一个心理委员会,并定期向PI报告 咨询委员会。将建立具有特定能力和里程碑的结构化课程 最好的培训个别居民对计划和研究计划的居民进行评论者 技能,兴趣和职业发展。我们从各个级别的研究中得到了广泛的支持, WU的教育,包括院长办公室以及参与部门和计划。 研究项目:Wu NCI R38 Starr计划每年最多支持四名居民评估者 来自参与部门。每个居民评估者将参与1 - 2年的专用,受保护 研究时间,没有所有临床责任。他们将制定与他们的研究计划 可能涉及进一步培训,课程,讲习班和职业的兴趣和先前经验 发展。特定的指标和随访,评估以及长期心理和职业的计划 我们的提案中包括开发。 WU Starr计划在跨学科肿瘤学临床医生培训中将利用重大的 我们大学的机构,部门和程序资源以满足Starr的既定目标 招募和保留出色卫生专业人员的计划,以促进其作为临床评估者的职业。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan C Fields其他文献

Ryan C Fields的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan C Fields', 18)}}的其他基金

Biospecimen Acquisition, Processing, and Classification Unit
生物样本采集、处理和分类装置
  • 批准号:
    10904039
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
Core B: Biospecimen Core
核心 B:生物样本核心
  • 批准号:
    10708577
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10708579
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
  • 批准号:
    10467047
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
Participant Engagement Unit
参与者参与单元
  • 批准号:
    10294014
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
  • 批准号:
    10298026
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
  • 批准号:
    10689094
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
WU-SN-TMC Biospecimen Core
WU-SN-TMC 生物样本核心
  • 批准号:
    10685421
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
WU-SN-TMC Biospecimen Core
WU-SN-TMC 生物样本核心
  • 批准号:
    10376525
  • 财政年份:
    2021
  • 资助金额:
    $ 42.31万
  • 项目类别:
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
在人性化、完全自体小鼠模型中推进精准肿瘤学
  • 批准号:
    10611842
  • 财政年份:
    2020
  • 资助金额:
    $ 42.31万
  • 项目类别:

相似海外基金

Bioengineering Research and Interdisciplinary Training – ESTEEMED (BRITE)
生物工程研究和跨学科培训 – EST​​EEMED (BRITE)
  • 批准号:
    10653560
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
Sex and Gender Enriched Neurology
性和性别丰富的神经病学
  • 批准号:
    10731695
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
SD CFAR EHE IS Consultation Hub
SD CFAR EHE IS 咨询中心
  • 批准号:
    10819873
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
胰腺癌发生和进展中的微生物失调
  • 批准号:
    10723251
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.
定义激酶相互作用途径,以增强抗癌功​​效并最大限度地减少激酶抑制剂药物的相关发病率。
  • 批准号:
    10644554
  • 财政年份:
    2023
  • 资助金额:
    $ 42.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了